CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

MYD88 L265P mutation (Waldenström's)

Gene: MYD88 · Type: mutation

Indications: Waldenström's Macroglobulinemia

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
IbrutinibWaldenström's MacroglobulinemiaINDICATED
FDA Label
Label
ZanubrutinibWaldenström's MacroglobulinemiaINDICATED
FDA Label
Label